Broadening the approaches to developing more effective vaccines

Vaccine

Volumn 17, Issue 13-14, 1999, Pages 1587-1595

  Babiuk, Lorne A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Genetic engineering; Marker vaccines; Vaccines

Indexed keywords

VACCINE;

CONFERENCE PAPER; GENETIC ENGINEERING; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; PRIORITY JOURNAL; VACCINATION;

ANIMALS; HUMANS; IMMUNIZATION; VACCINES; VACCINES, ATTENUATED; VACCINES, DNA;

EID: 0344141398     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00419-8     Document Type: Conference Paper

References (45)

1. Lo R.Y.C., Shewen P.E., Strathdee C.A., Greer C.N. Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1. Infect. Immun. 55:1987;1987-1996.
2. Shewen P.E., Wilkie B.N. Cytoxoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect. Immun. 35:1982;91-94.
3. Jim K., Guichon T., Shaw G. Protecting calves from pneumonic pasteurellosis. Vet. Med. 83:1988;1084-1087.
4. Harland R.J., Potter A.A., van Drunen Littel-van den Hurk S.et al. The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves. Can. Vet. J. 33:1992;734-741.
5. Deneer H.G., Potter A.A. Effect of iron restriction on the outer membrane proteins of Actinobacillus (Haemophilus) pleuropneumoniae. Infect. Immun. 57:1989;798-804.
6. Deneer H.G., Potter A.A. Iron-repressible outer membrane proteins of Pasteurella haemolytica. J. Gen. Microbiol. 135:1989;435-443.
7. Opdebeeck J.P. Vaccines against blood-sucking arthropods. Vet. Parasitol. 54:1994;205-222.
8. Berman P.W., Gregory T., Dowbenko D., Lasky L. Production of viral glycoproteins in genetically engineered mammalian cell lines for use as vaccines against immune deficiency retrovirus. Appl. Virol. Res. 1:1998;17-24.
9. Marciani D.J., Kensil C.R., Beltz G.A., Hung C.H., Cronier J., Aubert A. Genetically engineered subunit vaccine against feline leukemia virus: protective immune response in cats. Vaccine. 9:1991;89-96.
10. Valenzuela P., Medina A., Rutter W.J., Ammerer G., Rutter B.D. Synthesis and assembly of hepatitis B surface antigen particles in yeast. Nature. 298:1982;347-350.
11. Maeda S. Expression of foreign genes in insect cells using baculovirus vectors. Ann. Rev. Entomol. 34:1989;351-372.
12. Kowalski J., Gilbert S.A., van Drunen Littel-van den Hurk S., van den Hurk J., Babiuk L.A., Zamb T. Heat shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine. 11:1993;1100-1108.
13. King A.A., Harkness J.W. Viral contamination of fetal bovine serum. Vet. Rec. 97:1975;16.
14. van Drunen Littel-van den Hurk S., van Donkersgoed J., Kowalski J.et al. A subunit gIV vaccine produced by transfected mammalian cells in culture induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine. 12:1994;1295-1302.
15. Whitton I.L., Sheng N., Oldstone M., McKee T. A 'string of beads' vaccine comprising linked minigenes, confers protection from lethal virus challenge. J. Virol. 67:1993;348-352.
16. Hughes H.P.A., Babiuk L.A. The adjuvant potential of cytokines. Biotechnol. Ther. 3:1992;101-117.
17. Bosch J.C., De Jong M.C.M., Franken P.et al. An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus-1 infections in the field. Vaccine. 16:1998;265-271.
18. Minor P.D., John A., Ferguson M., Icenogle J.P. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion of a primary vaccine. J. Gen. Virol. 67:1986;693-706.
19. Farrell H.E., McLean C.S., Harley C., Efstathiou S., Inglis S., Minson A.C. Vaccine potential of a Herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J. Virol. 68:1994;927-932.
20. Forrester A., Farrell H., Wilkinson G., Kaye J., Davis-Poynter N., Minson T. Construction and properties of a mutant of Herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J. Virol. 66:1992;341-348.
21. Pastoret P.P., Brochier B., Languet B.et al. First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus. Vet. Rec. 123:1988;481-483.
22. Yilma T., Hsu D., Jones L., Owens S.et al. Protection of cattle against rinderpest and vaccinia virus recombinants expressing the HA and F genes. Science. 242:1988;1058-1061.
23. Wolff J.A., Malone R.W., Williams P., Ascadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
24. Hoffman S.L., Sedegah M., Hedstrom R.C. Protection against malaria by immunization with a plasmodium yoelei circums parazoite protein nucleic acid vaccine. Vaccine. 12:1994;1529-1533.
25. Donnelly J.J., Ulmer J.B., Liu M.A. Immunization with polynucleotides: a novel approach to vaccination. Immunol. 2:1993;20-26.
26. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
27. Anderson E.D., Mourich D.V., Fahrenkrug S.C., La Patra S., Shepherd J., Leong J.A. Genetic immunization of rainbow trout (Oncorhynchus mykiss) against infectious hematopoietic necrosis virus. Mol. Mar. Biol. Biotechnol. 5:1996;114-122.
28. Davis H.L., Michel M.L., Whalen R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Gen. 2:1993;1847-1851.
29. Yokonama M., Zhang J., Whitton J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:1995;2684-2688.
30. Cox G.J.M., Zamb T.J., Babiuk L.A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:1993;5664-5667.
31. Schubbert R., Renz D., Schmitz B., Doerfler W. Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA. Proc. Natl. Acad. Sci. USA. 94:1997;961-966.
32. Gilkeson G.S., Pippen A.M., Pisetsky D.S. Induction of cross-reactive anti-dsDNA antibodies in pre-autoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95:1995;1398-1402.
33. Puccetti M.B., Dolcher M.P., Madaio M.P., Migliorini P. Induction of anti-DNA antibodies in non-autoimmune mice by immunization with DNA-DNAase I complex. Clin. Exp. Rheumatol. 13:1995;7-10.
34. Conry R.M., Widera G., LoBuglio A.F.et al. Selected strategies to augment polynucleotide immunization. Gene Ther. 3:1996;67-74.
35. Kim J.J., Ayyavoo V., Bagarazzi M.L.et al. In vivo engineering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
36. Levitsky H. Accessories for naked DNA vaccines. Nat. Biotech. 15:1997;619-620.
37. Lewis P.J., Cox G.J.M., van Drunen Littel-van den Hurk S., Babiuk L. Polynucleotide vaccines in animals: enhancing and modulating responses. Vaccine. 15:1997;861-864.
38. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:1997;3138-3145.
39. Keller E.T., Burkholder J.K., Shi F.et al. In vivo particle-mediated cytokine gene transfer into canine oral mucosa and epidermis. Cancer Gene Ther. 3:1996;186-191.
40. Caplen N.J., Alton E.W.F.W., Middleton P.G.et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1:1995;39-46.
41. Stribling R., Brunette E., Liggitt D., Gaensler K., Debs R. Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. USA. 89:1992;11277-11281.
42. Sizemore D.R., Branstrom A.A., Sadoff J.C. Attentuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine. 15:1997;804-807.
43. Ertl H.C., Verma P., He Z., Xiang Z.Q. Plasmid vectors as antiviral vaccines. Ann. N. Y. Acad. Sci. 772:1995;77-97.
44. Condon C., Watkins S.C., Celluzi C.M., Thompson K., Falo L.D.J. DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. 2:1996;1122-1128.
45. Bos J.D., Kapsenberg M.L. The skin immune system: progress in cutaneous biology. Immunol. Today. 14:1993;75-78.